<SEC-DOCUMENT>0001104659-20-121583.txt : 20201105
<SEC-HEADER>0001104659-20-121583.hdr.sgml : 20201105
<ACCEPTANCE-DATETIME>20201105074021
ACCESSION NUMBER:		0001104659-20-121583
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20201105
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201105
DATE AS OF CHANGE:		20201105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37368
		FILM NUMBER:		201288719

	BUSINESS ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2033313d2_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:adap="http://adaptimmune.com/20201105">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_adap_adaptimmune.com_20201105 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20201105_20201105 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001621227 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:EntityCentralIndexKey">0001621227</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-11-05to2020-11-05" id="xdx2ixbrl0014" name="dei:EntityTaxIdentificationNumber">00-0000000</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="adap-20201105.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-11-05to2020-11-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001621227</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-05</xbrli:startDate>
        <xbrli:endDate>2020-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20201105__20201105_zOyzTSxR6Og6"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Current Report</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported):</b> <b><span id="xdx_90E_edei--DocumentPeriodEndDate_c20201105__20201105_zP5rdWYi5ZC3"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 5, 2020</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20201105__20201105_zhCYmeH1atO6"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:EntityRegistrantName">ADAPTIMMUNE THERAPEUTICS PLC</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified
in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20201105__20201105_zXa9gct4xCPg"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">England and Wales</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityFileNumber_c20201105__20201105_ztXSAVSNFe1a"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:EntityFileNumber">1-37368</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span title="::XDX::00-0000000"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_dxL_c20201105__20201105_z9xPtV3jFh0b" title="::XDX::00-0000000"><span style="-sec-ix-hidden: xdx2ixbrl0014">Not Applicable</span></span></span></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of<br />
incorporation)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer Identification No.)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20201105__20201105_zzcoeWA9KIhi"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:EntityAddressAddressLine1">60 Jubilee Avenue</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20201105__20201105_znokNuAfq29k"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:EntityAddressAddressLine2">Milton Park</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20201105__20201105_zBRbrSDaOUUd"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:EntityAddressCityOrTown">Abingdon, Oxfordshire</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20201105__20201105_z8RL0xlhyOj1"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:EntityAddressPostalZipCode">OX14 4RX</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressCountry_c20201105__20201105_zdz6Gd0syzDe"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">United Kingdom</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices,
including zip code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_906_edei--CityAreaCode_c20201105__20201105_zZsfVPwvqD3f"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:CityAreaCode">44</ix:nonNumeric></span>) <span id="xdx_905_edei--LocalPhoneNumber_c20201105__20201105_z4b9efkDzQ07"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:LocalPhoneNumber">1235 430000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_908_edei--WrittenCommunications_c20201105__20201105_zFMlj0To7wce"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90E_edei--SolicitingMaterial_c20201105__20201105_za04VpVHMIeg"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementTenderOffer_c20201105__20201105_zddtsJk5jxXb"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20201105__20201105_zwarYBZ9bwY1"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 35%; text-align: center"><b>Title of each class</b></td>
    <td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 26%; text-align: center"><b>Trading Symbol</b></td>
    <td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 35%; text-align: center"><b>Name of each exchange on which <br />
registered</b></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_90F_edei--Security12bTitle_c20201105__20201105_ztf3wnaSog6i"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:Security12bTitle">American Depositary Shares, each representing 6 Ordinary Shares, par value &#163;0.001 per share</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90B_edei--TradingSymbol_c20201105__20201105_z2pmGgSU1M29"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" name="dei:TradingSymbol">ADAP</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_904_edei--SecurityExchangeName_c20201105__20201105_zkcbobZni82e"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20201105__20201105_zhSjjpabqFn4"><ix:nonNumeric contextRef="From2020-11-05to2020-11-05" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 2.02</b></td><td><b>Results of Operations and Financial Condition.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 5, 2020, Adaptimmune Therapeutics plc (the &#8220;Company&#8221;)
issued a press release announcing its financial results for the third quarter ended September 30, 2020. A copy of the press release
is attached as Exhibit 99.1 and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information in Item 2.02 of this Form&#160;8-K, including
the attached Exhibit 99.1, shall not be deemed &#34;filed&#34; for purposes of Section&#160;18 of the Securities Exchange Act
of 1934, as amended, (the &#34;Exchange Act&#34;), or incorporated by reference in any filing made by the Company under the Securities
Act of 1933, as amended, or the Exchange Act, except as expressly set forth by the Company by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 9.01</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                                                                                                                                                                                                                                                                                                              <tr style="vertical-align: top">
<td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid"><b>Exhibit No.</b></td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><b>Description of Exhibit</b></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 6%"></td><td style="text-align: center; width: 10%"><a href="tm2033313d2_ex99-1.htm">99.1</a></td>
    <td style="width: 2%">&#160;</td><td style="width: 82%"><a href="tm2033313d2_ex99-1.htm">Press release dated November 5, 2020.</a></td></tr>
<tr style="vertical-align: top">
<td></td><td style="text-align: center">104</td>
    <td>&#160;</td><td>Cover Page Interactive Date File (embedded within the Inline XBRL document)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -58.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -58.3pt"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -58.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt">ADAPTIMMUNE THERAPEUTICS PLC</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 0.25in; width: 50%"><span style="font-size: 10pt">Date: November 5, 2020</span></td>
    <td style="width: 3%">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 47%"> /s/ Margaret Henry</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Name:&#160;&#160;Margaret Henry</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Title:&#160;&#160;&#160;&#160;Corporate Secretary</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LbMb/u7SoUOcIkPE27JFKW7NSOvfI/mW1g0xBEJyzpcjxEBktNI1MpwWRQ4HbNpaOYQCz8hoSvSOdL1JwM8CL9o6VsZ16w9MyTPomXEoS3/vnHdtsUpAzobxZBjNQU6T0QT2WxF89ZTMWVdonFY1KFPBnqlljU7xq/9wUE8y1Ly6pCOy1WQSiELZy2+IZRTDju7qQXy1kOepCAZdBSJjurXfmJt11MCyxsZn2R79d/AB5s5JKQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2033313d2_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="tm2033313d2_ex99-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Adaptimmune Reports Q3 Financial Results
and Business Update</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">- Data from Phase 1 Trial with ADP-A2AFP
in liver cancer presented at ILC confirm safety profile and demonstrate potential benefit for patients -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">- Safety and response data from dose escalation
cohorts of the SURPASS trial to be presented at SITC -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">- Durability of response data from patients
with synovial sarcoma from the Phase 1 ADP-A2M4 trial to be presented at CTOS -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">- Virtual Investor Day planned for November&nbsp;20,
2020 -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">- Financial guidance confirmed: funded into
2022 -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">- Conference call to be held today at 8:00
a.m.&nbsp;EST (1:00 p.m.&nbsp;GMT) -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PHILADELPHIA, PA., and OXFORDSHIRE, U.K., November&nbsp;5, 2020
(GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in cell therapy to treat cancer, today reported financial
results and provided a business update for the third quarter ended September&nbsp;30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Later this month, we will present data at SITC and CTOS.
Data to be presented at SITC from the dose escalation cohorts of our SURPASS trial confirm that ADP-A2M4CD8 is a highly active
agent across a range of tumors. At CTOS, we will present data regarding the durability of responses in synovial sarcoma, which
support our ambition to market ADP-A2M4 in 2022. And finally, at our Investor Day,&nbsp;I will lay out our broader strategy including
the opportunity we see for our late-stage pipeline,&rdquo; said Adrian Rawcliffe, Adaptimmune&rsquo;s Chief Executive Officer.
 &ldquo;Recruitment into our clinical trials has been steadily recovering following the first wave of COVID-19 and projected patient
numbers currently look good for the remainder of this year and into 2021.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Planned milestones
Q4 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Four posters to be presented at the virtual SITC meeting (November&nbsp;9-14)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>Poster entitled &ldquo;<FONT STYLE="background-color: white">Initial safety, efficacy, and product attributes from the SURPASS
trial with </FONT>ADP-A2M4CD8, a <FONT STYLE="background-color: white">SPEAR T-cell therapy incorporating an affinity optimized
TCR </FONT>targeting MAGE-A4 <FONT STYLE="background-color: white">and a </FONT>CD8&alpha; co-receptor&rdquo; with an update on
the dose escalation cohorts (6 patients in total)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>Poster entitled &ldquo;Inhibition of AKT signaling during expansion of TCR-Engineered T-Cells from patient leukocyte material
generates SPEAR T-Cells with enhanced functional potential <I>in vitro</I>&rdquo; with data indicating that AKT inhibition during
manufacture of SPEAR T-cells results in a more consistent expansion and phenotype of the final product</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>Two posters about the previously terminated ADP-A2M10 Phase 1 program: one for the lung cancer trial, and one for the triple
tumor trial in melanoma, urothelial, and head&nbsp;&amp; neck cancers</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Durability of response data from patients with synovial sarcoma from the ADP-A2M4 Phase 1 trial to be presented in an oral
presentation at the virtual CTOS conference (&ldquo;Immunotherapy in Sarcoma&rdquo; session on November&nbsp;19, 2020 from 9 a.m.&nbsp;to
10 a.m.&nbsp;EST)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Investor Day to be held on November&nbsp;20, 2020</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>CLINICAL UPDATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>As the management of COVID-19 at clinical sites continues to evolve, there has been an increase in recruitment and enrollment
during the latter part of Q3 and into Q4 for all ongoing clinical trials</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>SPEARHEAD-1 is recruiting well and remains on target to complete enrollment in the first half of 2021</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>On track to start a Phase 2 trial with ADP-A2M4CD8 in gastroesophageal cancers (gastric, esophageal, and esophagogastric junction)
in the first half of 2021</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Data update from the Phase 1 ADP-A2AFP trial presented in an oral presentation and poster, at the International Liver Congress,
confirmed safety profile and demonstrated potential benefit for patients with hepatocellular carcinoma. Four patients were treated
with ~5 billion or more transduced cells with best responses of one complete response, one patient with stable disease, and two
patients with progressive disease.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Presented SPEARHEAD-2 trial-in-progress poster at ESMO summarizing design for this first combination clinical trial with ADP-A2M4
and pembrolizumab</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Financial Results for the three and nine month periods
ended September&nbsp;30, 2020</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Cash / liquidity
position:</B> As of September&nbsp;30, 2020, Adaptimmune had cash and cash equivalents of $78.5 million and Total Liquidity<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP></FONT>of $399.9 million.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Revenue:</B> Revenue for the three and nine months ended September&nbsp;30, 2020 was $1.2 million and $2.5 million, respectively,
compared to $0.2 million and $0.4 million for the same periods in 2019. Revenue increased due to the commencement of development
activity under the Astellas Collaboration Agreement and increased development activity under the GSK Collaboration and License
Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Research
                                         and development (R&amp;D) expenses: </B>R&amp;D expenses for the three and nine months
                                         ended September&nbsp;30, 2020 were $24.1 million and $65.8 million, respectively, compared
                                         to $29.6 million and $77.1 million for the same periods in 2019. R&amp;D expenses were
                                         higher in the three and nine months ended September&nbsp;30, 2019 due to recognition
                                         of accrued purchase commitment expenses related to the supply of the Dynabeads<SUP>&reg;
                                         </SUP>CD3/CD28 technology of $5.0 million and in-process research and development as
                                         a result of entering into a collaboration agreement with Noile-Immune Biotech,&nbsp;Inc.
                                         in August&nbsp;2019. The nine-month period ended September&nbsp;30, 2019 also included
                                         $2.0 million of in-process research and development as a result of entering into a collaboration
                                         agreement with Alpine Immune Sciences,&nbsp;Inc. in May&nbsp;2019.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>General and administrative (G&amp;A) expenses:</B> G&amp;A expenses for the three and nine months ended September&nbsp;30,
2020 were $13.0 million and $32.6 million, respectively, compared to $10.7 million and $32.7 million for the same periods in 2019.
The increase in the three months ended September&nbsp;30, 2020 was primarily driven by an increase in professional fees, investment
in our IT systems, and costs associated with the buildout of our commercial capabilities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Net loss:</B> Net loss attributable to holders of the Company&rsquo;s ordinary shares for the three and nine months ended
September&nbsp;30, 2020 was $35.4 million and $93.5 million, respectively, and $(0.04) and $(0.11) per ordinary share, respectively,
compared to $39.3&nbsp;million and $107.8 million and $(0.06) and $(0.17) per ordinary share for the same periods in 2019.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Financial guidance</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company believes that its existing cash, cash equivalents
and marketable securities will fund the Company&rsquo;s current operations into 2022, as further detailed in the Company&rsquo;s
Quarterly Report on Form&nbsp;10-Q for the fiscal quarter ended September&nbsp;30, 2020, to be filed with the Securities and Exchange
Commission following this earnings release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Conference Call and
Webcast Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The Company will host
a live teleconference at&nbsp;</FONT>8:00 a.m.&nbsp;EST<FONT STYLE="background-color: white">&nbsp;(</FONT>1:00 p.m.&nbsp;GMT<FONT STYLE="background-color: white">)
today,&nbsp;</FONT>November&nbsp;5, 2020<FONT STYLE="background-color: white">. The live webcast of the conference call will be
available in the investor section of Adaptimmune&rsquo;s corporate website at www.adaptimmune.com. An archive will be available
after the call at the same address. To participate in the live conference call, please dial (833) 652-5917 (U.S. or Canada) or
+1 (430) 775-1624 (International). After placing the call, please ask to be joined into the Adaptimmune conference call and provide
the confirmation code (6183339).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP></FONT>Total liquidity is a non-GAAP financial measure, which is explained and reconciled to the most directly comparable
financial measures prepared in accordance with GAAP below.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Adaptimmune</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Adaptimmune is a clinical-stage biopharmaceutical company focused
on the development of novel cancer immunotherapy products for people with cancer. The Company&rsquo;s unique SPEAR<SUP>&reg;</SUP>
(Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer
across multiple solid tumors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This release contains &ldquo;forward-looking statements&rdquo;
within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These forward-looking statements involve certain
risks and uncertainties. Such risks and uncertainties could cause our actual results to differ materially from those indicated
by such forward-looking statements, and include, without limitation: the success, cost and timing of our product development activities
and clinical trials and our ability to successfully advance our TCR therapeutic candidates through the regulatory and commercialization
processes. For a further description of the risks and uncertainties that could cause our actual results to differ materially from
those expressed in these forward-looking statements, as well as risks relating to our business in general, we refer you to our
Quarterly Report on Form&nbsp;10-Q filed with the SEC on August&nbsp;6, 2020, and our other SEC filings. The forward-looking statements
contained in this press release speak only as of the date the statements were made and we do not undertake any obligation to update
such forward-looking statements to reflect subsequent events or circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Total Liquidity (a non-GAAP financial measure)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Total Liquidity (a non-GAAP financial measure) is the total
of cash and cash equivalents and marketable securities. Each of these components appears separately in the condensed consolidated
balance sheet. The U.S. GAAP financial measure most directly comparable to Total Liquidity is cash and cash equivalents as reported
in the condensed consolidated financial statements, which reconciles to Total Liquidity as follows (in millions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">September&nbsp;30,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December&nbsp;31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-size: 10pt; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Cash and cash equivalents</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">78.5</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">50.4</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Marketable securities &ndash; available-for-sale debt securities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">321.4</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">39.1</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Total Liquidity</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">399.9</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">89.5</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company believes that the presentation of Total Liquidity
provides useful information to investors because management reviews Total Liquidity as part of its management of overall liquidity,
financial flexibility, capital structure and leverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Condensed Consolidated Statement of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(unaudited, in thousands, except per share data)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three months ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Nine months ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September&nbsp;30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September&nbsp;30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; font-weight: bold">Revenue</TD><TD STYLE="width: 1%; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; font-weight: bold; text-align: right">1,193</TD><TD STYLE="width: 1%; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; font-weight: bold; text-align: right">237</TD><TD STYLE="width: 1%; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; font-weight: bold; text-align: right">2,456</TD><TD STYLE="width: 1%; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; font-weight: bold; text-align: right">394</TD><TD STYLE="width: 1%; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Operating expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Research and development (including losses accrued on firm purchase commitments of $0, $5,000, $0 and $5,000)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(24,067</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(29,617</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(65,791</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(77,147</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(13,001</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(10,741</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(32,557</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(32,662</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">(37,068</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">(40,358</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">(98,348</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">(109,809</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Operating loss</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(35,875</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(40,121</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(95,892</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(109,415</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Interest income</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,147</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">615</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,024</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,324</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other (expense) income, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,689</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">291</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,501</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(556</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Loss before income taxes</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(35,417</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(39,215</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(93,369</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(107,647</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Income taxes</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(15</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(87</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(110</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(154</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss attributable to ordinary shareholders</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(35,432</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(39,302</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(93,479</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(107,801</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold">Net loss per ordinary share</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Basic and diluted</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(0.04</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(0.06</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(0.11</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(0.17</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold">Weighted average shares outstanding:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Basic and diluted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">928,022,057</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">630,866,800</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">829,973,177</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">629,403,293</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Condensed Consolidated Balance Sheets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(unaudited, in thousands, except share data)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">September&nbsp;30,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December&nbsp;31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold">Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; width: 74%; font-size: 10pt; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">78,466</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">50,412</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Marketable securities - available-for-sale debt securities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">321,442</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">39,130</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other current assets and prepaid expenses (including current portion of clinical materials)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">26,825</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">30,947</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Total current assets</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">426,733</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">120,489</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Restricted cash</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,441</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,496</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Clinical materials</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">160</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,503</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Operating lease right-of-use assets, net of accumulated amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,775</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,789</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Property, plant&nbsp;and equipment, net of accumulated depreciation of $28,503 (2019: $23,649)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">26,943</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">31,068</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Intangibles, net of accumulated amortization</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,970</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,198</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">479,022</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">181,543</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Liabilities and stockholders&rsquo; equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Current liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Accounts payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">4,030</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">6,357</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Operating lease liabilities, current</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,619</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,493</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Accrued expenses and other accrued liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">24,615</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,363</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left; padding-bottom: 1pt">Deferred revenue, current</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,635</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,128</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Total current liabilities</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">34,899</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">34,341</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Operating lease liabilities, non-current</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">21,090</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22,966</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Deferred revenue, non-current</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">46,212</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other liabilities, non-current</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">615</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">598</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Total liabilities</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">102,816</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">57,905</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Stockholders&rsquo; equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Common stock - Ordinary shares par value &pound;0.001, 1,038,249,630 authorized and 928,525,410&nbsp;issued and outstanding (2019: 785,857,300 authorized and 631,003,568&nbsp;issued&nbsp;and outstanding)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">943</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Additional paid in capital</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">932,518</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">585,623</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Accumulated other comprehensive loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(8,494</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,264</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(549,143</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(455,664</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Total stockholders' equity</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">376,206</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">123,638</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">479,022</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">181,543</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Condensed Consolidated Cash Flow Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(unaudited, in thousands)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Nine months ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September&nbsp;30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Cash flows from operating activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; font-size: 10pt; text-align: left">Net loss</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(93,479</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(107,801</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-style: italic; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt">Depreciation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,151</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,406</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt">Amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">718</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">511</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Share-based compensation expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,352</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,495</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Unrealized foreign exchange (gains) losses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,102</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">522</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt">Other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,817</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(208</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-style: italic; text-align: left">Changes in operating assets and liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Decrease (increase) in receivables and other operating assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,345</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(20,075</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Decrease in non-current operating assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,291</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,468</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">(Decrease) increase in payables and other current liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(117</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,879</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left; padding-bottom: 1pt">Increase in deferred revenue</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">48,649</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,824</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Net cash used in operating activities</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(24,375</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(99,979</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Cash flows from investing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Acquisition of property, plant&nbsp;and equipment</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,174</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,425</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt">Acquisition of intangibles</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(496</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,036</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Maturity or redemption of marketable securities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">78,915</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">92,803</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment in marketable securities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(363,777</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(19,080</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Net cash (used in) provided by investing activities</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">(286,532</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">71,262</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Cash flows from financing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left">Proceeds from issuance of common stock, net of issuance costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">334,388</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font-size: 10pt; text-align: left; padding-bottom: 1pt">Proceeds from exercise of stock options</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,541</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">366</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Net cash provided by financing activities</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">339,929</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">366</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Effect of currency exchange rate changes on cash, cash equivalents and restricted cash</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(398</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Net increase (decrease) in cash, cash equivalents and restricted cash</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">27,999</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(28,749</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Cash, cash equivalents and restricted cash at start of period</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">54,908</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">72,476</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash, cash equivalents and restricted cash at end of period</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">82,907</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">43,727</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Adaptimmune Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Relations:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">S&eacute;bastien Desprez &mdash; VP, Communications and Investor
Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">T: +44 1235 430 583</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">M: +44 7718 453 176</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Sebastien.Desprez@adaptimmune.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Juli P. Miller, Ph.D. &mdash; Senior Director,&nbsp;Investor
Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">T: +1 215 825 9310</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">M: +1 215 460 8920</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Juli.Miller@adaptimmune.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection Last; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2033313d2_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2033313d2_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) 4L# 2(  A$! Q$!_\0
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M27MU%%%>D?BX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 4MJ%T9N' &#V(Z^^?<\^@K\
M8?\ @K!^R+^U'^USX.\):'\#O%'A2;P7X1.HZQXE^%NLW9\,^(_&'B>.-/[
MU.'7I7;P]/' LC$^'?$[^&+<LTLANMS2)'^RUV9HK2>6UB%Q<1QDVT)P%W8
M SD ')]@ ,=:_B*^)_\ P\(_X)Q?&Z3XH>+-5UWP7JWQ0\2:QXOU"YTGQ)-X
MN^%'Q&U9]6;6]?T76R?)T'5Y3#*3%+XJ,?CGRY!)$^UT8_IOA#P_C<TS^./R
M3..$,)G^1JG6X:I\6^SG0Q59Q<9PC[1-\U-0BY5(J,K.-E)\S7S_ !'C(87
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M+1M:M_B!J/B+P=:6WBS2_%U]8>&M:TG1)-6TK4[O18Q;F9O%2ZYXA.TN,^(
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MBMM>$"[RH(_+S]H\-^WU_P %/?A9^S-8*;_X*?LI6:^/_BV8-01M/UOQ(/[
MUK5=&F2 1221O(_@OX>RH[K)$;KQ<C-%M.VA\ F/_!/K_@J?\2/V=9_LFD?
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M3OA;H4^J?9?BE\1#J7AG3/'4>E#83X-T.?\ X15#&\J,(Q'XK\4>+Y2ICN?
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MO[-_CWPYX)^&GQ?TG7O"/QJN6U[_ (1GXJ:HW@LYT'0TF^''_",H5?7'5O\
MBJO%&Y_#S;H(W#(/I>&O#S,L?QEDW"_$&6.#Q$HU&XU:2=6E.E-PKX6I&I4C
M5A/W)QG1=9-:V4/>?'F&<X>&42QV$ES*UEHTTT]8R6EM]G8_J0#$Y4 "0KDN
M$(&T]L_0=<<^_-?"7P__ &S=/\=?MG?%;]D(?"CQSHMS\-?"&F>)%^(]^8F\
M/ZXX.D/.HT00K-H>BR#7M(_X1/Q#)+)'XL9)3;B,0'?\R?!+_@HS^U-\4/BK
MX#^'?C'_ ()J?'CX5>%_%^OV.C:Q\2]?N/B#_8?@_36;YM;UPZ_\$O"5N$48
M0HWB1B6PSN<L&]X^'7[<Q^(?[=/Q=_8J/PP;1O\ A5O@P>*_^%FCQVNIMKS>
M7X!)T@^#(_"Z'1'W^."WFOXJF+G1)OW7[Q0GSD.%<RRV&=1Q634\ZY.%JE:+
MI<58::P[56%-8B7U:M7I5)J3Y7"<HU9*HI5:5.,>9=T,RPN*Y5AI]5=\K72[
MT:B[*VBV5M'KK^B(6/L%7'<!/Y?_ *J"L?<*V>Y"?R__ %U^$GAG_@M9IGC3
M0/%&C^&OV:O%OB[XXGXCZUX ^'GP1\"^,I/%VK>+=.T+3$FU7QKK.O0_#I)/
M#?AV)1(IDC\+>+6)"E@^<1\SJ7_!6+]J;]G[QAI,/[:7[%NI?#GX<^)KW3K*
MQ\;^$[W56BTY96W&)M6C'BSPIXA\0DKA/#3^+?"$P7/[U\MO[WX8<81J?499
M7&-=QDX498KAA5:JA'FE[&@\8I5DE=-TZ;5TX\R:DUR_VYE6_,^SERRLNEV[
MZ=]7>Q_0*6;9NPQR>AZ\?CWR?R],T!FV%L,,'H.O/X]L#\_3%?C9\5_^"H&M
M^)/'<_P@_83^!&L?M<>,;/2]/O\ Q!XST/4GL/A=X/;Q! VJ:$=;UPK"DX>#
MY_*N?%'A012.ZH[*L;+Y_P#!_P#X*R^.M$^,^A?L^_MO_LYZE^SIXQ\8:VFD
M^&O$]C>ZJ?"CR:K>?V7H_P#;4/B!?LXT>24.K^+_  GXM\7^$A*.9HG42)C_
M ,0ZXR^K2Q;RR"J1HWE@W6H_ZW*R;]K_ *I*^,]EH_?=%:)OD:LWM_;&"VYG
M\>^O+O:U[6_$_=1555 SR.3C^6?7W&<=\XI4DW;NP4<#\@.>O^<U^<O[9/[>
M6C_L;_$+]G+P?XJ\$P:OX:^._B;4](\0^/[WQA'X<L/AIHV@ZY\/](U7Q7/H
M\?A?Q./$*1?\)U+KSP>=X60PZ)*KW$C2;U^-O$7_  4U_;#^(-AJWQ"_96_8
M1\9^-/@?I(BDM?'_ (T36AK'CK2E7:NK^"O!>@E+FYAW;L'PY_PF0D/+*" J
M\>!X*X@S##9?C\)3C2RB:4:>(KUL/A\/5FFZ<*:Q%:O3A[12C+]RDZK4744'
M&TBL1F.%PJ?,^9MW:BG>-]6[)-_/;I<_>!4 Z(5YXR.>?\]*>0H]2>XZ?T-?
MB3\./^"UGP#USX(>-?B%X[\.^)/ /Q3\":QIOAF]^!,DJ:KXM\6>)M>^T?V*
M/!,^?*D\/I_9.I_\)<TEN\O@M;>9;AKHW7A*7Q=Y=XO_ ."F_P"W]X'T<?%_
MQ)_P3QUS1/@7'(;R\74=5\8MX[T[PVB*W]J:XJ^'2WAN)55';7?$_A"*#;RT
M6UCN]&' '%U/%5,!C,I_L>O"I[*%+%UJ&$]M6Y83]G0EB?90K3<:E.WL567-
M.,')3O&'-_;.5-IN;LU=M0E*RUU=FVMGO;1,_H#$0R%P2/+V]AGOCGT_3FD4
M*,Q@?*%P3@<D]_3] <"OA+X4_MQ_#CXU_LC^./VJ_AQ97&IVWP_\#>.O$6O>
M M6O8M+U;0/%7@3P:_B/6?!NJZN\3Q1SCY%/B%8W@:'4UN" =\(ZS]B7]J.7
M]L']G_P]\<F\$CX=_P!OZQXDTA?"H\2#Q@=/;P_K,VCNSZV/#OACS7D> L$2
MS4*"WS.5PGSF(X9S?!X;-<5BLIJ4O[#Q*X;Q'/."E3KU(N4*,XJ;:=14JC2B
MY1Y:4FI-.+?I_6\.]Y)WU5HZ75_>]5?KW5S[!(SF/!V%-HX'/?\ GU ]>_-*
M(R"!@D!=I_$?H<D$]*^>OVG_ (UR_LY? ?XE?&Y?#/\ PFO_  KGPY)K[>%1
MK!\.)K1%_!"8O[<_L/Q(VDG,HDCGDLYXE VND4GE,OPS\1_^"G;> ?V$?A9^
MVS_PI-M7G^)WB33_  Z?AJ/B-_9ZZ(9-0\<0B0>.#\/Y9-9B#^#'V1)X1MI)
M)-8^5O+B9[@R[AO,LT5+&8/+)RC7Q2X9H2YH6JUY1E7IT(/F3O.FG."<5'EU
M<T[I1B<QP^%34I+1-R26W1R?2_1_D?K:6;9NPQR>AZ\?CWR?R],T!FV%L,,'
MH.O/X]L#\_3%?B!K?_!4/XS?%V6/0?V)/V2]?^-DUAIFDIXO^(.J7VI:;\,=
M"\53:9_:VM^"=#UJYB\)0^)?[ 62*)O$<OBCPI*LLSPQ>$)CY4@G_9L_X*OZ
MQXE^,NE_LU?M:_ O6?V=?BSKEVFC>'M0O7U7_A&O$&L:@91HFCOH>N"'Q'H7
M_"5.OE^"M=$GB>V\8%72(VARP]Q^'G&$<'4S"66THNC2DZN%>(PZXLI<D7.=
M6KPKS?6:=*$(N<YSA#E@G*4(Q7,<_P#;&"NE=ZRT=G9W=DEIK?IY^9^VBH$7
M:H*@_> 0@GV[_7\N..1T(7"87T.S<>I_SQD?4U\:?MB?MJ_![]BWX?P^+?B-
M<:CJ6L:[=-IO@SP)H$BR^)/%.ID3ILC B9-'T9'5/M'B&?%O!Y@8>85\N3\_
M_P#AOO\ X*97&B_\+>L?^"<%T?@V9OM)\-W'C1D^+ITP'EQHBM_PE/F#GY1\
M)"P7)QGYJX,MX.S[-<%#&T/84,LJS]GAZF*Q&'X<5:K[W[K#O$5:<J]1<LDX
M4X))K6:::*Q&8X3"S^K-RDTO>2BVDN\M[:]6WZ6L?N@%#*0.,=?I_D=_?/6F
M@8&!VKXH_8N_;@^$_P"VCX"N_$W@3[;X>\4>&;@Z=XZ^'7B&ZC_X23PGJB+"
MO[TJBC6M$E+$0^(X8_L\SJ1M1G55^V]P_NC]/\*\C,,'/*,3/!YQ3]GCZ3<:
MT*D.646FMDFXN+33C*,FI)W3:>FE"NL;!8C"R;A+2^COU^_O_5Z;3[(D=E"Y
M)#+Z8P>1V!SZ?7W_ !J_X*.?\% OV:/@7H_@_P %>*OAC\+_ -K/QE>^(GU3
M4_A?J^J>%-1TWP'I\>EZRC^,=6_MSPS\2(="UN".&>TL]%.G1W5S:'7)XY4C
MBQ<_LFT(NK<1S[9E((<$YW#GOZC(.1^?&:_EV\$?\$*(/#?Q#\9>/OVC/C#X
M*\)_L]^#_$FH:OI^F>']1GLKW7? VDZQKWDR>.M<UE?"7AGP' /#S:$99$?Q
M?&BJ_F31!2P^W\.<%P<\15Q?'&;UX8?)J5.4<+3C.%;B>4DX3HT9X:49TYOW
M97C.'+S2M.,;LX,[EFLG]6RY0O*]WO9)O1\V_97OINKGZ"?#7]J[X4_\.V_B
M#^TWJ'[)7PZ^&7PJ5?$YL_@79WN@IX)^(ZMK&C> U761_P *V\->'BWBCQ*J
M^&&:3PAXHC9-("^=<C;;QT?^"7O[77PC_:5G^.>I?#G]DKX=_LN:=\/-,\ 7
MOB/4/!EWX09/%G]O#QNBPZO_ ,(W\//!FW_A&)?#VM$R3M.1)-)M*1.Z'\??
M^"I/[>'@CXWV/@O]DW]F*WM;7]GSX:7NEV37>CVQT_2O'FI>'V;0?#^BZ$2J
M8^'OA53O=<$>,6/E*SQQHY^V+S2!_P $OO\ @E!XGT3Q2+;3OVA_VFX]6T\Z
M#=A1J>G:OX]T:+0_["#'#E?A1\.%4D)NB;QLOS,LOB@*WZ/F/A]@/]5J,Z^4
MXG#\2>('%GL^">$95J]:I3X.J--SK0J590Q%6*2BZF(C4E%MWE&*LO&P^:?[
M=*UO[#X?UDTDKR2?PM).*5[1Y;+2_D?)NN?\%5/V:+[1/&>L6W_!)?X$^+--
M\(V \2>)M3.J_#"+9IG_  F>B>'QKFJQW7[.%Z(V_P"$BU_0,EVF.[6D?.3(
M7_1S]B?]LKX+_'[]AW]K'XF?#/\ 8N^&GP]TCX2K\1)?$'[,W@^_\,ZMH'Q6
M6V^'.EZ^9-7?2/AWX>\.[O&@T\^%+N63PGXE9[?0%65KN-%LX_RQ_P"":_[$
MNH_M*?LQ?MU:W<0K;-XT^%Z? GX<;I(XQ>^.=%UK0OBR69G88QX@T'X8R*."
MZ:O+@Y0X\M_X(,?M)Q_!+]IWQS^SG\0)H?#>C?M!V.G>&;"/Q!9FPU'2_C#X
M%?69]#TI[<W-M%HJ>)M#U3Q?H$B2-ND\70^';9"JW,BM^->-5/ \+^*,>'LB
M<X\.Q7L82J5*E:3XP26DJE1U*THQE)1:E*HVN[22_M3P,X*RCCGZ,'B9G\<F
MJ<0\=>'/&'"/&,U2XQXQI*IP34<)UJ<>#ISP]&?NT>+W_KA+A2GQ=1:O.I27
M.I?J_P#\$F?^"A/[.G[3OQB\??"KX=?L6_"K]ECQ;#\/KGQ*-7\!WGA6>^\=
M:9I.OZ-I6I:+=-I/P=^%UPT=N^MPZ^C/)-&3L8P(IW0_.WAW_@JC^RQ\&?VV
M+OX8?%3_ ()X_"K]G[Q%X-^+OBOP3XN_: TB3P=J/B?PGJ(U;7O#T7C$)H_P
M7\+>(%T/Q<%22:?_ (2V-W\*ZZTD+>*+>2:V?\G?CQX!^*O_  2 _P""B-AX
MN\"6TS>'=!\3:CXT^$5UJIWZ9XW^$6LLFC:UX-UEF4%9H-"&L>'/&,FU7BE1
M/'J^7(O@O'Z^_'']E[]DK_@M1X7@_:2_9D^)>D?"O]I*Q\.Z5;_$/P[XB@@N
MK^]B$,?]C:!\5=&T:X&MVY5E'A>#XI^&)?$%M+X1::!(?$J1V9\._C>$S+.L
M=A)8!?\ (_R!^_%V2G=Q5E=)0=DE[EI2NK;W/Z3XD\-?!OAGB2GXB9O'C.?T
M;O&3@R%/#\:T>+N-:]?@KC-1G&,>,%3XMQ%;$1=23E&'&G^N,*;4[QFW*,OZ
M3O!_C'P9X]T:UU_P/XI\.^,M$FMM]CK'A?7-.UG2;E3D!X=2TJ:6*3D_*T;$
M=<$E2M>1?M5_'C0_V8/V>OB7\;=8:W#>#O#Y.AVLY3;K'BK6)TT/P=HI4_,5
MO?$NK:3;L1R%D<\<FOC+_@E/^P]XL_89_9Z\0_#OXC7WA#4OB+XU^(FM>-]9
MUCP3?:CJNE269TS1="T?2H]9UG0?#-U+Y,.B><J26<<:S:B["4J2Z?*'_!3#
M6]2_:Z_:[_9J_P""=W@B_!TBT\2:7\1_CI=VVJ)"-/TU=).L"*($!E\0>&/A
MZNK^(XU+%9#XZ\)NH);+?LW N14\\S?)?[83HY-"+XHXLY8RE*EA,.J5:O&+
MV4=%222Y_:RC'EDVD?YO^(N&R?ACB+BS).#<[7$N38>M4H\)<63IJC_K;R)J
MC5A13?(JC;<8R:O&,I<JL>4_\$IOVGOV0?@%\,OB%\3OCG^T'X4T_P#:#^/W
MCS4_$GCN+4])U5-4L=-TG7=<@T73"=#\-%"GB'6G\1>+1%AO./B#9M+*@9W_
M  5B_::_9$_:)^%/@+Q]\#OVA-"U/X\? KQSI/B;P#%X>7QAINJ76G:UK>@K
MXB_L1QX>(DUWPU_8NA>*XUV!XQX?8/C<%3]BHO\ @FW^PM%''"/V8?A*%4<#
M^P?S()G&[/OM%3G_ ()Q?L+GI^R]\(Q_W*\9S_Y%K](_UQ\/_P#6_P#URYN-
M?[9]I[2UN#^2WL_9>Q=/V3@Z'L_W?LO9\G+]F^I\"LNS?ZE]2YH6M\6N^][K
M3F\^Y\2_M)?MC7WQ4_X)$^,/VA/ =W;Z/XI\;?#_ ,-^$O$#VBQ[?#WB77_&
MV@?#_P"*.D,$8M&3'+XAM+,,JLZ:GI+L&W!C])?\$K_@EX7^"O[%7P;?0[#3
M9->^)OA+2_BSXPU^VB"ZCKNI^.;8>(=%75Y#S)<>&?#5QH?A/(8(J:"%50PD
M,GXS_ /X03>%_'_[=O\ P2)\;:U]ETGXFV6I_$/X :K='^SV;QSX?&A^._!&
MK-Y*S-*WB;PYHW@OQ5XSCCW;IO 'BE%91(SU]!_\$^_^"AGAW]ESPLG[%/[:
M4>J?!;X@?!W6]3T7P]XB\6Z9K5[I=_X8UK6_[<T'2=:EB2;^PPG]MM'X-\0,
ML?@R7P4WAC9<V[1;9>_BGA6%/@S.LBX6?OKC%<<0ITIPJ5JW!'%G",9\)RA2
MO[2<>$YRG1J2@JG+.JI2G'F2##9DGC/KF.BE:*AU2C*[OKLFUJM5U/W"^/7P
M=\&?M#_"7QM\(_']C;7V@>,-&O\ 1FF^S0WM]HNIO"[:+KVDF9MZ:YX<N!'K
M=H^!*MQ$FTM TB-^+/\ P1%\7^%?@_\ LF_M+^,_'OB#3?#OA+P%\:M:N_$6
MOW;^7I>G:3HG@SPV))2PYVQKQ@ L2R@#/(^B_P!H7_@I;\/O&%E=_ ']B+6Y
M_CE^TG\2K&^\-^"KSP5::E)X9\ /K*31MXWUGQL+9?#<)\+132>(C#YURD2:
M(8?%X@3)E_)#]E#X=>,_B7_P2(_;B\'>!-.OO$/BJW^-OAK5DTG3&5=4U+3?
M _\ PI_7M=C0L?F=O#VAZUA1EF X'%<W#.19N^!\[R3B*I+(LES_ (MX'4J%
M1JG6ITYXFM2>+=*?)4A2<5.,)RC&G6="3AS<LA8_$859K#&81<TE&<7)+1OE
MZ-73LG=_RJ6O4_57P[_P52^,?QON;V\_9)_8+^*OQK\ Z;=_8_\ A/M?\8Z1
M\.-.U&15&_\ L.5_#GBSPW<A2<[F\5J=H#,BD<?F]_P54_:&^*_QI^"'@K3?
MCE^Q-\3OV=/''A#XD:=>:!\3+K65\;^"&T[6-(UZ'6O!A\<Q^'/!\:MXE$6C
M:^_A@Q&60>'(TEDS;@']+O\ @GW_ ,%"/V-X_P!E;X1^"-3^)'P_^#GB+X:>
M!?#/@_Q?X*\<:UH?@N5-;T31TBUK6M#CF>&+6H?$VLF3Q+N@8R2#7F=U:9B9
M_P _?^"O?[;W@3]HWX20?"_X PZGX\\!>!/B/X=UGXG?%NRT]G\":=XADTO7
M=(\#>#-'U;Y8M?F\3O)K?B M&) L?AY0)B)1&GL\(9=4P'B'D>#P?AG4X>>1
M8R$)<8UL3QASPASU8^TG.I4CP?4<U"#IX>DFJCJJG&,E%J//F>(7]C2?]LJ[
M711ULKVLKS5K[NRTNW<ZW_@H_P##*S^/_P"W;_P3S^&_BB\:;3_B+\.O ]MX
MLE2Y"OJ.EQ^+M;US7HEW8W-)H2>("K' /F 9V@&OZ1]&T32?"VAZ3H'AS3K#
M1M#T2QM-.TG2=,M([#3=/T_2H]D6FZ5I<06.&*.",PHL8"B/&"_EK7\Q7_!4
M&#XF2?M<_L$S?!JV74/BGI?PD\"ZWX#M6 V:EXDT7Q=K?B'1=';.1C?HLBL3
M@$*2>IK]3?@__P %9/V3OB#X:DC^(_C./X"?$SP^LUCXV^&/Q7MM1\-ZCHWB
M31XH8=<T71]7DMTBUV2WUTRP6]K%_P 59<1(#<>$H&D*K\QQCDO$6;<%>&\\
MHA4SS*(8;&*%*@I5'2Y^+\53]HJ5-2FW548JE+V3BZDO91<9OEET9;B<)A,X
MSCZVU%\T?>ELXV5XWNOGKL[VVM\R_P#!=3X4Z//\$OAW^T/H)7PW\4OA+\0O
M"^C:1XKTF2+2_$K^'=<.L3G3H=52W60R>'/$EAHWB?PQYEP4@>#6VBA!O996
MX/\ X*\>*+OQS^R1^PIXUU$!;_QC\2OA?XHNP!@#5-?^&DOB!@ . !*9L <8
MXQ7E'[7O[0%[_P %5_BG\-/V/_V4+/6-9^%'A_Q9I?C/XI?%Z;1WM=,@10=%
MDU>+1M?C$T^A>&/#VN:YE/$L,4/C'Q7K%G9V]J%LQ+/]%_\ !;WP/>^%_P!E
M+X WOA#0-1U/PK\'_B_X6M+Z.S;,6@^&8_!6O>'='DU0'#^2\W]C>%U9@"W]
MO;L#//T_"L:N5XSP;R/.Y1IY^N+N*J]2A5E&-7#\)XN$5AZ<X.?/1J5)+$NG
M2FN:=JO(I<K,,4OK2SK&X%-JRC?6SE!KFDK[K?7HG;U_?'.TI&J;1N"D_P"S
MSDG/'7Z=Z_GS_9RP/^"[O[7N.!_PI^\Y]!_9/[/^3^5?H;\)/^"D7[''Q@O_
M (=^'_!7Q9M[CQM\2YK30_#_ (%NM"\01^([359%60:=K5G#H;?V(Z#*-<W$
MT?AW<C>7<%)"\GYY?LX@G_@NO^UZ,\GX/7O/N=&^ %?%\(Y;G&499XH83.,J
MK9+/_4>:<:\90G-PXMX8CI&4*;M.5XW2<7:+3:E%R]#,<1AL6\H>%DI7JIJV
MMHN*[MO3S\^NAD_\$*OA_H']I_M9_%*:SL;KQ6_Q&;X?6NHD?Z38>'%N=3U_
M6+")B^P0^(-?.E2SHT;[WT"WVNFTK)^F'_!37P9X?\8_L+_M&VWB.QMM1@\/
M_#?5_&>D?;!N6P\1^"D&NZ+JB%2/WL5S;)DG@(6&,OD?"'_!"K_D3/VLS_U<
M%-^NB#_"OT7_ ."B0!_8=_:E/<?!/Q\/_*+(?ZUZ7%M?$_\ $<(R^U_K?P;^
M'^J*7IIS.ZL_D3EO_).1UWI3;];M6_!:]['S9_P1B\ ^&?"'[ _PQ\0:/9)9
MZI\2-:\<^,?%%T#EM1U2+QCKW@[29G[ +X;\/Z'&BCHPW$_. /G+_@OQX;T6
M3]F3X0>-7LX&\4Z#\=M)T?2-7*J-0L]*USP7X^U?7-)B*Y7;,WAS1KDC<2/[
M'4G).3]B?\$B_P#E'9^SJ?\ IR^('_JX/'O^%?+W_!?O'_#&_P /L?\ 1P/A
M@_A_PK+XN ?RI9!B\9+QSI5'*3G_ *^U8<S>K2Q>)AR:6O%1IQ@EMRQ2ULV3
MBDEPI;O23^=U_G<\B_X*U^$M*^+GQO\ ^"7'@GQB+FYT;XE^/I/#'BY+-OL'
MV[2?&WC#X :#K8P/N[AK>X(,[=V*_H4TW3-/T:PLM*TNRM]/L-/M5M;*TM8!
M'96=F@&(E5=BJ L8P >3EF!&6/X/?\%&CG]J/_@CM_V6'3!^7BWX "OWX3!3
M/^S^HW+7S_&$G'A3PZPE[4Z>%XNG&"224O\ 76LG):?R0C"VR26BUOV9?_OF
M;/JZB5_6*_7\S^:*P^#O@+4/^"^NL63>';.WTC2M*/Q7.E06*_8+[QV/@]H&
ML_VXX 4%$\1:Y_PE32\Y\7J9<LQR?Z1+FSM[RUEL+R&*YM+FTG@GMYU#I<(Y
M(VN"2&5@>F"20",8%?@7H'_*?_Q;_P!D@C_]4[X<K^@$<E&[+%(!^!;&?P//
M/6CQ#Q&*D^#7*3<H\#\(<K;=]:=;F>]]4E=WO[L>RMCD;][..EN)ZT][:Q4&
MOS?J?RV?L#Z<_A7X0_\ !;'X;Z/-,OAGP+X4\;V7AO3&(!T]1X6_:1T26),\
MGS8-"TD\8Y1<U^F'_!%5PG_!/WX>$XX\8?%,G_PMM9P?SR/IFOB/_@F=X*?X
MF^-O^"R7PZ6Y%K+\1O$DG@S[2<;;%O&NM?M,:0K'/(,1U8R*<C&W)Z8KD/\
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MB^[>O-?_ %P3O>Z>FCTM;=6;OZ^=K_C'I^5.#^]Q^[Y?YGRA^UU^T%X,\/\
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MCSR4JLL/&<J:FZO)4K4ZE&-25-0E6IS@IN<9(_,']M;P1XDN?^"I?_!/O5]
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MSPYI&I7_ ('U&7^QW;5?!L\Z2R>'Y3+H6BL9+402C^Q[< !$1F]494 (QP$
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MXQ\7_#SQAX8\21(ZKJWA/QEX!\0^%_%.@3R++*7>T\1PB5&6*=7CAB*GP^^
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M\:/H$OB_36UGX4>+?!MY);>(6\(:"98WE;:^D(8&A8R9^G A+/"5Q$J*@/\
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-]](VBOP44O**6MC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>adap-20201105.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K85w7xRiXgen8uNbXAsWaeD6bPtzp5x+ekhuWhybRnKzywidmeRsCh8eiFWsYkF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:adap="http://adaptimmune.com/20201105" elementFormDefault="qualified" targetNamespace="http://adaptimmune.com/20201105">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://adaptimmune.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="adap-20201105_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="adap-20201105_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>adap-20201105_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>adap-20201105_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://adaptimmune.com/role/Cover" xlink:href="adap-20201105.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://adaptimmune.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2033313d2_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adap-20201105.xsd" xlink:type="simple"/>
    <context id="From2020-11-05to2020-11-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001621227</identifier>
        </entity>
        <period>
            <startDate>2020-11-05</startDate>
            <endDate>2020-11-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-11-05to2020-11-05">0001621227</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-11-05to2020-11-05">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-11-05to2020-11-05" id="xdx2ixbrl0014">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType contextRef="From2020-11-05to2020-11-05">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-11-05to2020-11-05">2020-11-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-11-05to2020-11-05">ADAPTIMMUNE THERAPEUTICS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-11-05to2020-11-05">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-11-05to2020-11-05">1-37368</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-11-05to2020-11-05">60 Jubilee Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2020-11-05to2020-11-05">Milton Park</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2020-11-05to2020-11-05">Abingdon, Oxfordshire</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="From2020-11-05to2020-11-05">OX14 4RX</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="From2020-11-05to2020-11-05">GB</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="From2020-11-05to2020-11-05">44</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-11-05to2020-11-05">1235 430000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2020-11-05to2020-11-05">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-11-05to2020-11-05">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-11-05to2020-11-05">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-11-05to2020-11-05">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-11-05to2020-11-05">American Depositary Shares, each representing 6 Ordinary Shares, par value &#xa3;0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-11-05to2020-11-05">ADAP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-11-05to2020-11-05">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-11-05to2020-11-05">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140408425861128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 05, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  05,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-37368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ADAPTIMMUNE THERAPEUTICS PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001621227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">60 Jubilee Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Milton Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Abingdon, Oxfordshire<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">OX14 4RX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1235 430000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing 6 Ordinary Shares, par value &#163;0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M^KZ^AH8/$L];,J=[_!EJ,:@W6]5C6)>E:H\_A?<HN9\;[O\2Q0]02P,$%
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M)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ "CUE40=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  */651
M-V("!.X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    "  */651F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  H]95'^[XUE>P0
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M2P$"% ,4    "  */651)!Z;HJT   #X 0  &@              @ $&$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  */65199!Y
MDAD!  #/ P  $P              @ 'K$0  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"   U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2033313d2_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://adaptimmune.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2033313d2_8k.htm">tm2033313d2_8k.htm</File>
    <File>adap-20201105.xsd</File>
    <File>adap-20201105_lab.xml</File>
    <File>adap-20201105_pre.xml</File>
    <File>tm2033313d2_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2033313d2_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2033313d2_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "adap-20201105_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adap-20201105_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "adap-20201105.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "adap",
   "nsuri": "http://adaptimmune.com/20201105",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2033313d2_8k.htm",
      "contextRef": "From2020-11-05to2020-11-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://adaptimmune.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2033313d2_8k.htm",
      "contextRef": "From2020-11-05to2020-11-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://adaptimmune.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-20-121583-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-20-121583-xbrl.zip
M4$L#!!0    (  H]95&O-*:E/@,  )@,   1    861A<"TR,#(P,3$P-2YX
M<V2U5EUOVC 4?=ZD_0<OKY,):457*+2JJ)BJTJZ"]6-/DY-<P"*Q,]LIT%\_
M.Q\0(# ^-IZ<>\\Y/M>YUZ%Y-0T#] 9"4LY:EE.I6@B8QWW*ABWKJ8^O^^W;
M6PM=77[ZB/2O^1ECU*$0^ UTPSU\RP;\ CV0$!KH&S 01'%Q@9Y)$)L([]
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M.K=D #;;:&BB@-BP.P/@J,2H4",A]XC''4\VF.\72=33>9A"MX! 1MN$Z*J
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M?7BPC@*ZQ*[0Z#>L$(&50:#2:T]'1@2,HT8$*D-0$1,"//,LVQ+^)H0L(9Y
M LT#.!GZ$*&"3/:B50;Z)VQ!HJWH-_?3D]4RR5/;9:@I<=9+ >;J/DI+#X(0
MP)1.1)&&V .:GOQU]3>DHKQ <,.6',O5<1?[S8JEP'I:5I4K%#HL*AHLDB"
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M-5L[*3B%+^=?CX\]EOP_4$L#!!0    (  H]95$O9?%DKR,   VF 0 6
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M;0>&7>RC/=I'5PX/L.*:@C9O_:M#?( ;@ <F VL._Z$_AZ 6HRN &\N7#E"
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M<??C<)OQHSY\NKGX-W>R?NU\O3[[?U!+ 0(4 Q0    (  H]95&O-*:E/@,
M )@,   1              "  0    !A9&%P+3(P,C Q,3 U+GAS9%!+ 0(4
M Q0    (  H]95&6<JB7_0H  -^'   5              "  6T#  !A9&%P
M+3(P,C Q,3 U7VQA8BYX;6Q02P$"% ,4    "  */651\IGC@U@'   Z60
M%0              @ &=#@  861A<"TR,#(P,3$P-5]P<F4N>&UL4$L! A0#
M%     @ "CUE41!(QB=2$@  U&$  !(              ( !*!8  '1M,C S
M,S,Q,V0R7SAK+FAT;5!+ 0(4 Q0    (  H]95$O9?%DKR,   VF 0 6
M          "  :HH  !T;3(P,S,S,3-D,E]E>#DY+3$N:'1M4$L%!@     %
-  4 20$  (U,      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
